Sharps Compliance (SMED) Scheduled to Post Quarterly Earnings on Thursday

Sharps Compliance (NASDAQ:SMEDGet Rating) will announce its earnings results before the market opens on Thursday, May 12th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Shares of SMED stock opened at $4.37 on Thursday. The stock has a fifty day moving average of $5.33 and a two-hundred day moving average of $6.55. The firm has a market capitalization of $84.11 million, a PE ratio of 6.07 and a beta of 0.01. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.40 and a current ratio of 3.85. Sharps Compliance has a 1 year low of $4.08 and a 1 year high of $17.47.

A number of analysts have recently weighed in on the stock. Roth Capital lowered shares of Sharps Compliance from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $12.00 to $7.00 in a research note on Tuesday, April 5th. StockNews.com assumed coverage on Sharps Compliance in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Finally, Zacks Investment Research raised Sharps Compliance from a “sell” rating to a “hold” rating in a research note on Tuesday. Five investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.83.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC raised its holdings in shares of Sharps Compliance by 15.6% in the 4th quarter. Geode Capital Management LLC now owns 254,292 shares of the industrial products company’s stock worth $1,813,000 after purchasing an additional 34,355 shares in the last quarter. Deutsche Bank AG grew its position in Sharps Compliance by 1.2% in the fourth quarter. Deutsche Bank AG now owns 230,743 shares of the industrial products company’s stock worth $1,645,000 after buying an additional 2,838 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Sharps Compliance by 156.9% in the third quarter. Bank of New York Mellon Corp now owns 129,090 shares of the industrial products company’s stock valued at $1,068,000 after buying an additional 78,838 shares in the last quarter. Norges Bank acquired a new stake in shares of Sharps Compliance during the 4th quarter valued at $876,000. Finally, Barclays PLC boosted its stake in shares of Sharps Compliance by 57.4% during the 4th quarter. Barclays PLC now owns 45,353 shares of the industrial products company’s stock worth $324,000 after acquiring an additional 16,534 shares in the last quarter. 56.06% of the stock is currently owned by institutional investors.

Sharps Compliance Company Profile (Get Rating)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Featured Stories

Earnings History for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.

Sharps Compliance (SMED) Scheduled to Post Quarterly Earnings on Thursday

Sharps Compliance (NASDAQ:SMEDGet Rating) will announce its quarterly earnings results before the market opens on Thursday, May 12th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Shares of NASDAQ SMED opened at $4.37 on Thursday. Sharps Compliance has a 12-month low of $4.08 and a 12-month high of $17.47. The company has a market cap of $84.11 million, a PE ratio of 6.07 and a beta of 0.01. The stock has a 50 day simple moving average of $5.33 and a 200-day simple moving average of $6.55. The company has a current ratio of 3.85, a quick ratio of 3.40 and a debt-to-equity ratio of 0.06.

Several hedge funds have recently modified their holdings of the company. Morgan Stanley boosted its position in shares of Sharps Compliance by 244.7% during the 2nd quarter. Morgan Stanley now owns 603,414 shares of the industrial products company’s stock valued at $6,215,000 after purchasing an additional 428,350 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Sharps Compliance by 35.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 666,777 shares of the industrial products company’s stock valued at $4,754,000 after purchasing an additional 174,370 shares during the last quarter. Norges Bank bought a new stake in Sharps Compliance during the fourth quarter worth approximately $876,000. Bank of New York Mellon Corp grew its position in Sharps Compliance by 156.9% in the third quarter. Bank of New York Mellon Corp now owns 129,090 shares of the industrial products company’s stock worth $1,068,000 after buying an additional 78,838 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Sharps Compliance by 15.6% in the fourth quarter. Geode Capital Management LLC now owns 254,292 shares of the industrial products company’s stock valued at $1,813,000 after buying an additional 34,355 shares in the last quarter. Institutional investors own 56.06% of the company’s stock.

Several brokerages have weighed in on SMED. Zacks Investment Research raised Sharps Compliance from a “sell” rating to a “hold” rating in a research note on Tuesday. StockNews.com began coverage on shares of Sharps Compliance in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Finally, Roth Capital lowered shares of Sharps Compliance from a “buy” rating to a “neutral” rating and decreased their target price for the company from $12.00 to $7.00 in a research report on Tuesday, April 5th. Five investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.83.

Sharps Compliance Company Profile (Get Rating)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Read More

Earnings History for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.